ArticleESC heart failure2025
A new staging system for hereditary transthyretin amyloidosis in the era of specific amyloidosis therapies.
Gabriela Neculae et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it